The European Conference on Clinical Trials in Orphan Drugs (CTOD2024) is a pivotal event scheduled for May 28-29, 2024, in London, UK. This conference serves as a vibrant platform for professionals in the clinical trials community, including academia, clinical research organizations, and pharmaceutical and biomedical sectors. Attendees will engage with leading experts and discuss innovative strategies and best practices pertinent to the development of orphan drugs and treatments for rare diseases.

The agenda encompasses critical topics such as the selection of trial sites, identifying patients, fostering relationships with patient groups, and navigating clinical trials across European borders. Key discussions will focus on preparing for pre-launch activities, understanding the clinical trial landscape beyond major countries, and optimizing the development of orphan drugs.

CTOD2024 invites all stakeholders aiming to advance the orphan drug field to join this collaborative event, share insights, and enhance disease awareness across Europe, making it a vital occasion for networking and knowledge exchange in the clinical trials domain.